Regeneron hopes for full FDA approval of COVID-19 antibody cocktail
The treatment currently has emergency use authorization.
News 12 Staff
•
Oct 14, 2021, 4:54 PM
•
Updated 925 days ago
Share:
More Stories
Hometown Heroes in New York City
9ds ago
Nobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
207ds ago0:21
Biden administration announces $600M to produce COVID tests and will reopen website to order them
219ds ago1:54
Hochul: Updated COVID vaccine to be available in NY in the coming days
226ds ago2:22
New and rare COVID variant detected in NYC wastewater; Gov. Hochul urges caution
240ds ago2:39
City health officials: COVID-19 cases on the rise as new variant emerges
240ds agoHometown Heroes in New York City
9ds agoNobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
207ds ago0:21
Biden administration announces $600M to produce COVID tests and will reopen website to order them
219ds ago1:54
Hochul: Updated COVID vaccine to be available in NY in the coming days
226ds ago2:22
New and rare COVID variant detected in NYC wastewater; Gov. Hochul urges caution
240ds ago2:39
City health officials: COVID-19 cases on the rise as new variant emerges
240ds agoA new medicine to treat COVID-19 could be on the way as the Food and Drug Administration has started its review of 's COVID-19 antibody cocktail.
The Tarrytown-based biotech company says the FDA accepted its priority review application and they are hoping to receive full approval
The treatment currently has emergency use authorization.
Regeneron wants full approval to treat patients infected with the virus who are not in the hospital.
